A Randomized Trial to Determine the Role of Valganciclovir for Asymptomatic Cytomegalovirus Infected Hearing Impaired Infants (ValEAR Trial)

Project: Research project

Project Details

StatusActive
Effective start/end date7/6/176/30/22

Funding

  • University of Utah (10041913-021/5U01DC014706-02)
  • National Institute of Deafness and Communication Disorders (10041913-021/5U01DC014706-02)